Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study

• Main Authors: Megna M (Author), Ruggiero A (Author), Tommasino N (Author), Brescia C (Author), Martora F (Author), Cacciapuoti S (Author), Potestio L (Author)
• Format: Book
• Published: Dove Medical Press, 2024-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Matteo Megna,* Angelo Ruggiero,* Nello Tommasino, Claudio Brescia, Fabrizio Martora, Sara Cacciapuoti, Luca Potestio Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy*These authors contributed equally to this...